Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pathway Health Corp V.PHC

Pathway Health Corp is a providers of out-of-hospital pain management services in Canada. The Company owns and operates approximately 9 community-based clinics across 4 provinces. The companies patient care programs utilize an interdisciplinary approach that includes trained pain specialists, physical and occupational therapists, psychologists, nurses and other healthcare providers.

TSXV:PHC - Post Discussion

Pathway Health Corp > LOI to Acquire Assets of National Cannabinoid Clinic
View:
Post by Betteryear2 on Mar 04, 2022 9:05am

LOI to Acquire Assets of National Cannabinoid Clinic

TORONTOMarch 4, 2022 /CNW/ - Pathway Health Corp. (TSXV: PHC) (FrankfurtKL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces that it has entered into a Letter of Intent (the "LOI") to acquire the operating assets of National Cannabinoid Clinics Inc. ("NCC").  The acquisition of NCC's operating assets adds approximately 1,500 active patients to the Company's existing base and continues to expand the Company's telemedicine footprint in Canada. Management expects to close the transaction in the second quarter of the fiscal 2022. 
Be the first to comment on this post